Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma

Published:2022-07-14 Issue:5 Volume:40 Page:941-952
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Zhang Ping¹²,Shi Cunzhen¹,Song Yue¹²³,Li Zhaoming¹,Zhang Mingzhi¹³^ORCID,Jin Mengyuan¹

Affiliation:

1. Department of Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

2. Academy of Medical Sciences of Zhengzhou University Zhengzhou Henan China

3. State Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory for Esophageal Cancer Research The First Affiliated Hospital of Zhengzhou University Zhengzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3042

Reference30 articles.

1. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma

2. Current management of nasal NK/T‐cell lymphoma;Au WY;Oncology,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma;Chinese Medical Journal;2024-08-23

2. Advances and challenges of immunotherapies in NK/T cell lymphomas;iScience;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP